Search Results 391-400 of 18218 for Immunode
Patients with human immunodeficiency virus (HIV) are eligible for the study provided they meet the other protocol criteria in addition to the following:.
Has known human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection or hepatitis B virus (HBV) infection. Has on-going high blood ...
Diagnosed with an immunodeficiency or cystic fibrosis; Immunotherapy for any allergen; Pregnancy. Participating Mayo Clinic locations. Study statuses change ...
No immunosuppression or immunodeficiency. No acute illness at time of vaccination. Determined by medical history and clinical judgment to be eligible for ...
Diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (with corticosteroids at >10 mg/day prednisone or equivalent) or any other ...
Women of childbearing potential; Women who are pregnant or are currently breastfeeding; Myopathy grade > 2; Known positive status for human immunodeficiency ...
Mayo Clinic researchers have unraveled the molecular mechanisms that affect which cells infected with human immunodeficiency virus (HIV) die and which ...
Known history of human immunodeficiency virus (HIV) infection. Active clinically serious infections > CTCAE Grade 2; Active Hepatitis B or hepatitis C ...
Primary immunodeficiency; Rhinitis; Sinusitis. Procedures performed. Immunotherapy. Interests. Allergen immunotherapy; Asthma triggers and exacerbations ...
History of status epilepticus in the 3 years prior to screening. 5. Primary or secondary immunodeficiency 6. Suicide attempts in the past year 3 years 7 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.